A rapid diagnostic test that delivers simultaneous results for both COVID-19 and influenza viruses, helping clinicians make informed decisions and patients receive appropriate care quickly.
Manufactured by
Derby, United Kingdom
About SureScreen Established in 1996, SureScreen have been providing proactive, bespoke diagnostic solutions to organizations just like yours for nearly 25 years. Believing early diagnosis is key to preventing disruption to both time and finances, SureScreen deliver tailored services and products across the UK and Europe.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
ProGnosis Biotech S.A.
Greece · 2 relevant products
NewScen Coast Bio-Pharmaceutical Co., Ltd.
China · 1 relevant product
Xiamen Biotime Biotechnology Co., Ltd.
China · 2 relevant products
Beijing Jinwofu Bioengineering Technology Co.,Ltd.
China · 4 relevant products
Advin Biotech, Inc.
United States · 1 relevant product
Jiangsu Macro & Micro-Test Med-Tech Co., Ltd.
China · 1 relevant product
MedLevensohn
Brazil · 2 relevant products
Qingdao Hightop Biotech Co., Ltd
China · 1 relevant product
Hangzhou AllTest Biotech Co.,Ltd
China · 7 relevant products
Healgen Scientific LLC
United States · 2 relevant products
66 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →5 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 115 closest product alternatives
ProGnosis Biotech S.A. · Greece
Rapid antigen test for simultaneous detection of influenza A & B and COVID-19 using advanced antigen-antibody technology. Delivers fast, reliable results for respiratory infection screening in clinical settings. ELISA and lateral flow formats available for point-of-care and laboratory use.
NewScen Coast Bio-Pharmaceutical Co., Ltd. · China
Rapid immunochromatographic test for simultaneous detection of COVID-19 and influenza A/B antigens from respiratory specimens. Delivers results in 15-20 minutes, enabling quick differential diagnosis in clinical and point-of-care settings. Single-use test cassette with high sensitivity and specificity for viral antigen identification.
Xiamen Biotime Biotechnology Co., Ltd. · China
Multiplex rapid diagnostic test for simultaneous detection of SARS-CoV-2 antigen and influenza A/B viruses.
Beijing Jinwofu Bioengineering Technology Co.,Ltd. · China
A rapid antigen test kit for simultaneous detection of Influenza A, Influenza B, and COVID-19 (SARS-CoV-2). This combo test enables efficient screening for multiple respiratory viruses in a single procedure.
Advin Biotech, Inc. · United States
Multiplex rapid test simultaneously detecting COVID-19, influenza A, and influenza B from a single specimen. FDA cleared with results available in 5 minutes.
Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. · China
Rapid molecular detection kit for simultaneous identification of SARS-CoV-2, influenza A, and influenza B viruses. Utilizes isothermal amplification technology for quick diagnostic results.
MedLevensohn · Brazil
A rapid diagnostic combo test for simultaneous detection of COVID-19 and Influenza H1N1 antigens.
Xiamen Biotime Biotechnology Co., Ltd. · China
Rapid diagnostic test for influenza virus detection. Provides quick confirmation of influenza infection for clinical decision-making.
Qingdao Hightop Biotech Co., Ltd · China
Rapid antigen test for simultaneous detection of SARS-CoV-2 and Influenza A+B from respiratory specimens. Delivers results within 15-20 minutes, enabling quick triage and differential diagnosis in clinical and point-of-care settings. Colloidal gold immunochromatographic technology provides high sensitivity and specificity for acute respiratory infection management.
Hangzhou AllTest Biotech Co.,Ltd · China
A rapid diagnostic test that simultaneously detects COVID-19 and Influenza A+B antigens using a nasopharyngeal swab sample.
Healgen Scientific LLC · United States
Rapid diagnostic test for simultaneous detection of influenza A/B and coronavirus antigens from nasopharyngeal or oropharyngeal specimens. CLIA-waived immunofluorescence assay enabling point-of-care results within minutes for respiratory pathogen screening and patient triage.
Reagen Inc. · United States
Multiplex rapid test kit for simultaneous detection and differentiation of COVID-19, Influenza A, Influenza B, and RSV in a single test strip. Provides results in under 10 minutes for respiratory pathogen screening.
103 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products